Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $2.34 billion. The enterprise value is $2.53 billion.
| Market Cap | 2.34B |
| Enterprise Value | 2.53B |
Important Dates
The last earnings date was Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 76.19 million shares outstanding. The number of shares has decreased by -3.57% in one year.
| Current Share Class | 76.19M |
| Shares Outstanding | 76.19M |
| Shares Change (YoY) | -3.57% |
| Shares Change (QoQ) | -2.07% |
| Owned by Insiders (%) | 1.70% |
| Owned by Institutions (%) | 110.81% |
| Float | 74.86M |
Valuation Ratios
The trailing PE ratio is 16.81 and the forward PE ratio is 12.70.
| PE Ratio | 16.81 |
| Forward PE | 12.70 |
| PS Ratio | 1.19 |
| Forward PS | 1.17 |
| PB Ratio | 2.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.16 |
| P/OCF Ratio | 10.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.65, with an EV/FCF ratio of 12.05.
| EV / Earnings | 16.83 |
| EV / Sales | 1.29 |
| EV / EBITDA | 9.65 |
| EV / EBIT | 10.61 |
| EV / FCF | 12.05 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.28 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 2.27 |
| Debt / FCF | 2.92 |
| Interest Coverage | 7.15 |
Financial Efficiency
Return on equity (ROE) is 17.25% and return on invested capital (ROIC) is 16.47%.
| Return on Equity (ROE) | 17.25% |
| Return on Assets (ROA) | 6.86% |
| Return on Invested Capital (ROIC) | 16.47% |
| Return on Capital Employed (ROCE) | 14.84% |
| Weighted Average Cost of Capital (WACC) | 6.87% |
| Revenue Per Employee | $457,739 |
| Profits Per Employee | $35,068 |
| Employee Count | 4,280 |
| Asset Turnover | 0.90 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MD has paid $53.34 million in taxes.
| Income Tax | 53.34M |
| Effective Tax Rate | 26.22% |
Stock Price Statistics
The stock price has increased by +80.97% in the last 52 weeks. The beta is 0.61, so MD's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +80.97% |
| 50-Day Moving Average | 27.02 |
| 200-Day Moving Average | 23.91 |
| Relative Strength Index (RSI) | 76.14 |
| Average Volume (20 Days) | 669,621 |
Short Selling Information
The latest short interest is 4.37 million, so 5.74% of the outstanding shares have been sold short.
| Short Interest | 4.37M |
| Short Previous Month | 4.73M |
| Short % of Shares Out | 5.74% |
| Short % of Float | 5.84% |
| Short Ratio (days to cover) | 5.77 |
Income Statement
In the last 12 months, MD had revenue of $1.96 billion and earned $150.09 million in profits. Earnings per share was $1.83.
| Revenue | 1.96B |
| Gross Profit | 511.69M |
| Operating Income | 237.98M |
| Pretax Income | 203.43M |
| Net Income | 150.09M |
| EBITDA | 261.75M |
| EBIT | 237.98M |
| Earnings Per Share (EPS) | $1.83 |
Balance Sheet
The company has $425.84 million in cash and $612.00 million in debt, with a net cash position of -$186.17 million or -$2.44 per share.
| Cash & Cash Equivalents | 425.84M |
| Total Debt | 612.00M |
| Net Cash | -186.17M |
| Net Cash Per Share | -$2.44 |
| Equity (Book Value) | 849.62M |
| Book Value Per Share | 11.16 |
| Working Capital | 148.35M |
Cash Flow
In the last 12 months, operating cash flow was $226.89 million and capital expenditures -$17.29 million, giving a free cash flow of $209.59 million.
| Operating Cash Flow | 226.89M |
| Capital Expenditures | -17.29M |
| Depreciation & Amortization | 23.78M |
| Net Borrowing | -25.20M |
| Free Cash Flow | 209.59M |
| FCF Per Share | $2.75 |
Margins
Gross margin is 26.12%, with operating and profit margins of 12.15% and 7.66%.
| Gross Margin | 26.12% |
| Operating Margin | 12.15% |
| Pretax Margin | 10.38% |
| Profit Margin | 7.66% |
| EBITDA Margin | 13.36% |
| EBIT Margin | 12.15% |
| FCF Margin | 10.70% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.57% |
| Shareholder Yield | 3.57% |
| Earnings Yield | 5.95% |
| FCF Yield | 8.96% |
Analyst Forecast
The average price target for MD is $29.17, which is -5.01% lower than the current price. The consensus rating is "Hold".
| Price Target | $29.17 |
| Price Target Difference | -5.01% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 3.02% |
| EPS Growth Forecast (3Y) | 7.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |